One invasive spinal NST was diagnosed via histopathology from surgical biopsy and necropsy samples with additional immunohistochemistry performed (CNPase-positive, CD18-negative) to rule out other tumor types (Figure 1). This evidence concerns the gene ITGB2 and neoplasm.